Notice2024-26497
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 14, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 220 (Thursday, November 14, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 220 (Thursday, November 14, 2024)]
[Notices]
[Pages 90021-90022]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-26497]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-14: NCI Clinical and Translational Cancer Research.
Date: December 6, 2024.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W242, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Rockville, Maryland 20850, 240-276-6372,
<a href="/cdn-cgi/l/email-protection#6913061c13010018290408000547070001470e061f"><span class="__cf_email__" data-cfemail="add7c2d8d7c5c4dcedc0ccc4c183c3c4c583cac2db">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Innovative Technologies for Cancer Research.
Date: January 30-31, 2025.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-6371,
<a href="/cdn-cgi/l/email-protection#751110161900101f3518141c195b1b1c1d5b121a03"><span class="__cf_email__" data-cfemail="87e3e2e4ebf2e2edc7eae6eeeba9e9eeefa9e0e8f1">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-4: NCI Clinical and Translational Cancer Research.
Date: February 4-5, 2025.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W264, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
[[Page 90022]]
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850, 240-276-7286,
<a href="/cdn-cgi/l/email-protection#addeccc1dbd8cecec2edc0ccc4c183c3c4c583cac2db"><span class="__cf_email__" data-cfemail="d5a6b4b9a3a0b6b6ba95b8b4bcb9fbbbbcbdfbb2baa3">[email protected]</span></a>.
Name of Committee: National Cancer Institute Initial Review
Group; Institutional Training and Education Study Section (F).
Date: February 11-12, 2025.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W234, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W234, Rockville, Maryland 20850, 240-276-6368,
<a href="/cdn-cgi/l/email-protection#b4e7c0dbddd7d5d586f4d9d5ddd89adadddc9ad3dbc2"><span class="__cf_email__" data-cfemail="762502191f15171744361b171f1a58181f1e58111900">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SPORE (P50) Review SEP-III.
Date: February 25-26, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W514, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Wlodek Lopaczynski, M.D., Ph.D., Assistant
Director, Office of the Director, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W514, Rockville, Maryland 20850, 240-276-6340, <a href="/cdn-cgi/l/email-protection#503c3f20313327103d31393c7e3e39387e373f26"><span class="__cf_email__" data-cfemail="2d41425d4c4e5a6d404c444103434445034a425b">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI U54-SPORE-SEP II.
Date: March 5-6, 2025.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W522, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Klaus B. Piontek, Ph.D., Chief, Research
Programs Review Branch, Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W522,
Rockville, Maryland 20850, 240-276-5413, <a href="/cdn-cgi/l/email-protection#593235382c2a77293036372d3c3219373031773e362f"><span class="__cf_email__" data-cfemail="ddb6b1bca8aef3adb4b2b3a9b8b69db3b4b5f3bab2ab">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer
Construction; 93.393, Cancer Cause and Prevention Research; 93.394,
Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment
Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers
Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control,
National Institutes of Health, HHS)
Dated: November 8, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-26497 Filed 11-13-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 14, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.